Association of Comorbid and Metabolic Factors with Optimal Control of Type 2 Diabetes Mellitus

Satyajeet Roy, A. Sherman, Mary Joan Monari-Sparks, Olga Schweiker, N. Jain, Etty Sims, M. Breda, G. Byraiah, R. Belecanech, Michael Coletta, C. Barrios, K. Hunter, J. Gaughan
{"title":"Association of Comorbid and Metabolic Factors with Optimal Control of Type 2 Diabetes Mellitus","authors":"Satyajeet Roy, A. Sherman, Mary Joan Monari-Sparks, Olga Schweiker, N. Jain, Etty Sims, M. Breda, G. Byraiah, R. Belecanech, Michael Coletta, C. Barrios, K. Hunter, J. Gaughan","doi":"10.4103/1947-2714.175197","DOIUrl":null,"url":null,"abstract":"Background: Type 2 diabetes mellitus (T2DM) is a poorly controlled epidemic worldwide that demands active research into mitigation of the factors that are associated with poor control. Aims: The study was to determine the factors associated with suboptimal glycemic control. Materials and Methods: Electronic medical records of 263 adult patients with T2DM in our suburban internal medicine office were reviewed. Patients were divided into two groups: Group 1 [optimal diabetes control with glycosylated hemoglobin (HbA1c) of 7% or less] and Group 2 (suboptimal diabetes control with HbA1c greater than 7%). The influence of factors such as age, gender, race, social history, comorbid conditions, gestational diabetes, family history of diabetes, diabetes management, statin use, aspirin use, angiotensin convertase enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) use, body mass index (BMI), blood pressures, lipid profile, and urine microalbumin level were analyzed in the two groups. Results: In the suboptimal diabetes control group (N = 119), the majority (86.6%) of the patients were 41-80 years old. Factors associated with the suboptimal control were male gender [odds ratio (OR) 2.6, 95% confidence interval (CI), 1.579-4.321], Asian ethnicity (OR 1.4, 95% CI, 0.683-3.008), history of peripheral arterial disease (PAD; OR 3.9, 95% CI, 1.017-14.543), history of congestive heart failure (CHF; OR 3.9, 95% CI, 1.017-14.543), elevated triglycerides (OR 1.004, 95% CI, 1.000-1.007), and elevated urine microalbumin level of 30 mg/24 h or above (OR 4.5, 95% CI, 2.446-8.380). Patients with suboptimal diabetes control had a 3.8 times greater odds (95% CI, 1.493-6.885) of receiving the insulin and oral hypoglycemic agent together. Conclusions: In adult patients with T2DM, male gender, Asian ethnicity, CHF, PAD, management with insulin along with oral hypoglycemic agents, hypertriglyceridemia, and microalbuminuria were associated with suboptimal control.","PeriodicalId":19703,"journal":{"name":"North American Journal of Medical Sciences","volume":"44 1","pages":"31 - 39"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"19","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"North American Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/1947-2714.175197","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 19

Abstract

Background: Type 2 diabetes mellitus (T2DM) is a poorly controlled epidemic worldwide that demands active research into mitigation of the factors that are associated with poor control. Aims: The study was to determine the factors associated with suboptimal glycemic control. Materials and Methods: Electronic medical records of 263 adult patients with T2DM in our suburban internal medicine office were reviewed. Patients were divided into two groups: Group 1 [optimal diabetes control with glycosylated hemoglobin (HbA1c) of 7% or less] and Group 2 (suboptimal diabetes control with HbA1c greater than 7%). The influence of factors such as age, gender, race, social history, comorbid conditions, gestational diabetes, family history of diabetes, diabetes management, statin use, aspirin use, angiotensin convertase enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) use, body mass index (BMI), blood pressures, lipid profile, and urine microalbumin level were analyzed in the two groups. Results: In the suboptimal diabetes control group (N = 119), the majority (86.6%) of the patients were 41-80 years old. Factors associated with the suboptimal control were male gender [odds ratio (OR) 2.6, 95% confidence interval (CI), 1.579-4.321], Asian ethnicity (OR 1.4, 95% CI, 0.683-3.008), history of peripheral arterial disease (PAD; OR 3.9, 95% CI, 1.017-14.543), history of congestive heart failure (CHF; OR 3.9, 95% CI, 1.017-14.543), elevated triglycerides (OR 1.004, 95% CI, 1.000-1.007), and elevated urine microalbumin level of 30 mg/24 h or above (OR 4.5, 95% CI, 2.446-8.380). Patients with suboptimal diabetes control had a 3.8 times greater odds (95% CI, 1.493-6.885) of receiving the insulin and oral hypoglycemic agent together. Conclusions: In adult patients with T2DM, male gender, Asian ethnicity, CHF, PAD, management with insulin along with oral hypoglycemic agents, hypertriglyceridemia, and microalbuminuria were associated with suboptimal control.
合并症和代谢因素与2型糖尿病最佳控制的关系
背景:2型糖尿病(T2DM)是一种控制不良的世界性流行病,需要积极研究缓解与控制不良相关的因素。目的:本研究旨在确定与血糖控制欠佳相关的因素。材料与方法:对我院郊区内科263例成年T2DM患者的电子病历进行回顾性分析。患者分为两组:1组[糖化血红蛋白(HbA1c)≤7%的糖尿病最佳控制]和2组(糖化血红蛋白大于7%的糖尿病次优控制)。分析两组患者年龄、性别、种族、社会历史、合并症、妊娠糖尿病、糖尿病家族史、糖尿病管理、他汀类药物使用、阿司匹林使用、血管紧张素转换酶抑制剂(ACE-I)或血管紧张素受体阻滞剂(ARB)使用、体重指数(BMI)、血压、血脂、尿微量白蛋白水平等因素的影响。结果:亚优糖尿病对照组(N = 119)中,年龄在41 ~ 80岁的患者占86.6%;与次优对照相关的因素有男性[比值比(OR) 2.6, 95%可信区间(CI) 1.579-4.321]、亚洲种族(OR 1.4, 95% CI, 0.683-3.008)、外周动脉疾病史(PAD;OR 3.9, 95% CI, 1.017-14.543),充血性心力衰竭史(CHF;OR 3.9, 95% CI, 1.017-14.543),甘油三酯升高(OR 1.004, 95% CI, 1.000-1.007),尿微量白蛋白水平升高30 mg/24 h或以上(OR 4.5, 95% CI, 2.446-8.380)。糖尿病控制不佳的患者同时使用胰岛素和口服降糖药的几率(95% CI, 1.493-6.885)高出3.8倍。结论:在T2DM、男性、亚洲种族、CHF、PAD的成年患者中,胰岛素联合口服降糖药、高甘油三酯血症和微量白蛋白尿与次优控制相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信